Abstract:Jin Liang, 1, &ast Yuanfang Hu, 1, &ast Mingxia Fu, 2 Na Li, 1 Fengxia Wang, 1 Xiaojun Yu, 1 Bing Ji 1 1 Department of Laboratory Medicine, Binzhou Medical University Hospital, Binzhou, People's Republic of China; 2 Department of Laboratory Medicine, Binzhou People's Hospital, Binzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Bing Ji, Email Objective: To investigate the molecular epidemiology of Staphylococcus aureus ( S. aureus ) isolated from patients in the Yellow River Delta region and to construct antibiotic resistance profiles in different genetic backgrounds. Methods: Antibiotics susceptibility testing, staphylococcal protein A ( spa ) typing and accessory gene regulator ( agr ) typing were performed for all the 204 strains. Isolates with the positive mecA gene and heterogeneous vancomycin-intermediate S. aureus (hVISA) were subjected to multilocus sequence typing (MLST) and Staphylococcal chromosomal cassettes mec (SCC mec ) typing. Results: Thirty-nine MRSA strains were identified by mecA gene. Twenty-two hVISA isolates including 9 MRSA and 13 methicillin-sensitive S. aureus (MSSA) strains were confirmed, the rest isolates (n = 182) were vancomycin-susceptible S. aureus (VSSA). 94.9% of MRSA and 63.6% of hVISA belonged to agr I. Fifty-seven distinct spa types including 5 novel types were mainly t309 (30.9%), t078 (11.8%) and t437 (11.8%). Fourteen sequence types (STs) containing 3 new STs were classified into 3 clone complexes (CCs) and 7 singletons among MRSA and hVISA isolates. Most MRSA isolates (87.2%) belonged to type IV SCC mec . Conclusion: The predominant genotype among MRSA population was ST59-t437- agr I-IVa (53.8%), followed by ST72-t2431- agr I-IVF (15.4%). ST72 and CC5 (ST5/965/7197) were the most common hVISA clones. Both CC59 (ST59/7437) and ST72 clones were resistant to erythromycin and clindamycin among MRSA population. Strains of MSSA with phenotypic hVISA (MS-hVISA) exhibited a striking genetic diversity accompanied by the diversification of drug resistance patterns. Keywords: Staphylococcus aureus , heterogeneous vancomycin-intermediate S. aureus , a ccessory gene regulator, multilocus sequence typing, erythromycin For more than 140 years since its discovery, Staphylococcus aureus has remained a pathogen of clinical concern. Among the various models of S. aureus , the real challenge is the emergence of MRSA. 1 Over a long period of evolution, MRSA acquired the mecA gene encoding a penicillin-binding protein (PBP2a) that displays low affinity for most semisynthetic penicillins by horizontal transfer, resulting in resistance to β-lactams. 2 Due to the misuse of antibiotics in humans, the "cunning" MRSA has integrated antibiotic resistance genes into its genome in various ways, leading to the emergence of multidrug-resistant strains, making it more difficult to treat, and as a result, the spread of MRSA has become more unchecked worldwide. To understand the molecular epidemiology from different geographical distributions, researchers adopt typing methods including SCC mec, spa, agr and MLST as a means for the characterization and discrimination of isolates based on their genetic characteristics. However, the antibiotics susceptibility results of strains from the same background differed. ST22 lineage from a Kuwaiti hospital showed a high resistance rate of 69.2% and 84.6% to gentamicin and trimethoprim-sulfamethoxazole, respectively, 3 in contrast, the clone from China displayed no resistance activity to both antibiotics. 4 Strains ST8-IVa-t008 from China and Germany were both susceptible to clindamycin but differed in resistance to ciprofloxacin (100%, 37.5%). 5,6 ST59-IV-t437 from England was resistant to erythromycin, clindamycin and tetracycline, however, this lineage from the Chinese pediatric population was phenotypically resistant to trimethoprim-sulfamethoxazole, ciprofloxacin and chloramphenicol in addition to the above antibiotics. 7,8 Gram-positive bacterial infections including MRSA are majorly treated using glycopeptide antibiotics, in which vancomycin is the first-line agent. Vancomycin binds the D-alanine-D-alanine terminus of the murein precursor, forming a complex that in turn blocks transpeptidation as well as transglycosylation, leading to incomplete or inefficient peptidoglycan cross-linking during cell wall synthesis. The resultant cell wall is weak and -Abstract Truncated-

Transcriptional Profiling of the Two-Component Regulatory System VraSR in Staphylococcus Aureus with Low-Level Vancomycin Resistance.

Advances in Two-Component Signal Transduction System VraSR of Staphylococcus

Investigation of Virulence Genes and Resistance Genes in a Group of Staphylococcus Aureus Isolated in Yuhang, China

Molecular Epidemiology and Antibiotic Resistance Profiles of Methicillin-Resistant Staphylococcus aureus Strains in a Tertiary Hospital in China.

An induced mutation of ABC-transporter component VraF(K84E) contributes to vancomycin resistance and virulence in Staphylococcus aureus strain MW2

Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia

The Vancomycin Resistance-Associated Regulatory System VraSR Modulates Biofilm Formation of Staphylococcus Epidermidis in an Ica-Dependent Manner.

The functional small RNA interactome reveals targets for the vancomycin-responsive sRNA RsaOI in vancomycin-tolerant Staphylococcus aureus

Comparative Proteomics-Based Identification of Genes Associated with Glycopeptide Resistance in Clinically Derived Heterogeneous Vancomycin-Intermediate Staphylococcus Aureus Strains

Insights into the molecular basis of reduced vancomycin susceptibility among three prominent Staphylococcus aureus clonal complexes

Staphylococcus aureus response and adaptation to vancomycin

The VraSR Regulatory System Contributes to Virulence in Streptococcus Suis Via Resistance to Innate Immune Defenses

The Staphylococcus Aureus ArlRS Two-Component System Regulates Virulence Factor Expression Through MgrA.

The Role of <i>graRS </i>in Regulating Virulence and Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus

The Role of graRS in Regulating Virulence and Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus

Combatting Antibiotic-Resistant Staphylococcus aureus: Discovery of TST1N-224, a Potent Inhibitor Targeting Response Regulator VraRC, through Pharmacophore-Based Screening and Molecular Characterizations

Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive Staphylococcus Aureus Strains

Repeated Exposure of Vancomycin to Vancomycin-Susceptible Staphylococcus aureus (VSSA) Parent Emerged VISA and VRSA Strains with Enhanced Virulence Potentials

Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus

Staphylococcus aureus acquires resistance to glycopeptide antibiotic vancomycin via CXCL10

Genotypic Variations Between Wild-Type and Small Colony Variant of Staphylococcus Aureus in Prosthetic Valve Infectious Endocarditis: a Comparative Genomic and Transcriptomic Analysis.